Stemtech Corporation (STEK)
OTCMKTS
· Delayed Price · Currency is USD
0.0218
-0.0027 (-11.02%)
Apr 28, 2025, 3:52 PM EDT
Stemtech Company Description
Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia.
Its products enhance and support the work of the body’s stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health.
The company offers its dietary supplements products under the RCM System, stemrelease3, Stemflo MigraStem, OraStem, and D-Fuze brand names; and skincare products under the Cellect One brand name.
It serves through independent distributors. Stemtech Corporation is headquartered in Miramar, Florida.
Stemtech Corporation
Country | United States |
Founded | 2005 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
CEO | Charles Arnold |
Contact Details
Address: 4851 Tamiami Trail North Naples, Nevada 34103 United States | |
Phone | 954 715 6000 |
Website | stemtech.com |
Stock Details
Ticker Symbol | STEK |
Exchange | OTCMKTS |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
ISIN Number | US85859W1027 |
SIC Code | 2833 |
Key Executives
Name | Position |
---|---|
Charles S. Arnold | Chief Executive Officer and Director |
John W. Meyer | President, Chief Operating Officer and Director |
Shrilakshmi Vadlapatla | Chief Financial Officer |
Tufan Obuz | Chief Administrative Officer |
Alejandro Carrillo | Vice President of Global Sales |
David E. Price Esq. | Secretary |